Obstacle Negotiation in Older People With and Without Vision Impairment
Impact of Stepping Over Obstacles of Different Contrast and Height on Gait and Eye Movements in Older Adults With and Without Vision Impairment
1 other identifier
interventional
200
1 country
1
Brief Summary
Falls are common among people with vision impairment and can lead to devastating health consequences. Understanding the functions of vision and how the visual characteristics of obstacles in the walking path impact the gait of people with vision impairment is necessary to create strategies to prevent falls in this population. The purpose of this study is to determine how adults with vision impairment change their gait behavior when stepping over obstacles that vary in height and contrast to the ground. We will then determine the mechanisms of gaze behavior that correlate to the gait behavior.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 14, 2023
CompletedFirst Submitted
Initial submission to the registry
May 4, 2023
CompletedFirst Posted
Study publicly available on registry
June 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
November 13, 2025
November 1, 2025
5.7 years
May 4, 2023
November 12, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Vertical foot clearance, lead limb
Distance from lowest point of foot (heel or toe) to top of obstacle
During a single intervention visit (Study Visit 2), up to 2-3 hours in duration.
Foot placement variability
Standard deviation of position of toe to obstacle over 2-4 steps before the obstacle
During a single intervention visit (Study Visit 2), up to 2-3 hours in duration.
Obstacle crossing speed
Speed from lead toe off immediately before the obstacle to trail heel down immediately after the obstacle.
During a single intervention visit (Study Visit 2), up to 2-3 hours in duration.
Gaze sequencing
Sequence of fixations from start of trial to end of trial, normalized to the total duration and divided into 100 equal segments
During a single intervention visit (Study Visit 2), up to 2-3 hours in duration.
Study Arms (2)
Low Vision Group
EXPERIMENTALAt a single study visit, the group of low vision participants will be asked to perform a series of short walking trials. During each trial they will walk at a self-selected speed along a walkway (6 meters in length) that may or may not contain an obstacle to step over. The trials will be randomly varied with regard to an obstacle's presence, height, and contrast from the walkway surface. Repeated trials of each condition variation will be performed during the visit.
Control Group
ACTIVE COMPARATORAt a single study visit, the group of age-matched participants without low vision will be asked to perform a series of short walking trials. During each trial they will walk at a self-selected speed along a walkway (6 meters in length) that may or may not contain an obstacle to step over. The trials will be randomly varied with regard to an obstacle's presence, height, and contrast from the walkway surface. Repeated trials of each condition variation will be performed during the visit.
Interventions
In the walking trials, when an obstacle is present, the obstacle height and obstacle contrast level will be varied across the trial repetitions. Each participant will be exposed to obstacles of two heights: the first will be 1 centimeter in height, and the second will be approximately 20% of the subject's leg length (ranging in physical height between 15 - 22 centimeters to cover a range of leg lengths in the population). Obstacles (of both heights) will also be painted such that their measured luminance (or contrast) level against the floor luminance is varied. High contrast obstacles will have ≥80% Michelson contrast and low contrast obstacles will have ≤30% Michelson contrast.
Eligibility Criteria
You may qualify if:
- Age 18 or over
- Able to walk independently
- Either have normal vision, or impaired vision.
- Impaired vision is defined as binocular visual acuity of 20/25 or worse with or without a central scotoma; and/or binocular visual field that is restricted to an average of 100 degrees in diameter or less
- Control subjects will have visual acuity of 20/40 or better.
You may not qualify if:
- Not cleared by a medical provider for moderate physical activity
- Self-report or have a history of: vestibular disorder or deafness
- Medical history of any condition that affects the ability to walk for up to 2 hours with breaks, such as feeling dizzy or faint, chest pain, palpitations, pain or numbness in the legs, shortness of breath,
- Cognitive limitations either by self-report or a score on the Mini Mental State Exam below 24 (out of 30)
- Walking or gait abnormalities, such as those caused from an injury, surgery, severe arthritis, or neurological condition such as Parkinson's disease
- Unable to walk without any walking aids such as a walker, cane, guide dog, or oxygen tank.
- Does not speak English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Indiana University
Bloomington, Indiana, 47405, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 4, 2023
First Posted
June 5, 2023
Study Start
April 14, 2023
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
November 13, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share